Autologous Platelet-Rich Plasma Versus Dextrose Prolotherapy for the Treatment of Chronic Recalcitrant Plantar Fasciitis

PM and R

Volumn 6, Issue 2, 2014, Pages 152-158

  Kim, Eunkuk ^a   Lee, Jong Ha ^b  

^a Korea National Sport University   (South Korea)

^b Kyung Hee University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANESTHETICS, LOCAL; CHRONIC DISEASE; DISABILITY EVALUATION; FASCIITIS, PLANTAR; FEMALE; GLUCOSE; HUMANS; INJECTIONS; LIDOCAINE; MALE; MIDDLE AGED; MOBILITY LIMITATION; PAIN MEASUREMENT; PLATELET-RICH PLASMA; SINGLE-BLIND METHOD; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84894269011     PISSN: 19341482     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pmrj.2013.07.003     Document Type: Article

References (39)

1. Peerbooms J.C., van Laar W., Faber F., Schuller H.M., van der Hoeven H. Use of platelet rich plasma to treat plantar fasciitis: Design of a multi centre randomized controlled trial. BMC Musculoskelet Disord 2010, 11:69.
2. Puttaswamaiah R., Chandran P. Degenerative plantar fasciitis: A review of current concepts. Foot 2007, 17:3-9.
3. Goff J.D., Crawford R. Diagnosis and treatment of plantar fasciitis. Am Fam Physician 2011, 84:676-682.
4. Díaz-Llopis I.V., Rodríguez-Ruíz C.M., Mulet-Perry S., Mondéjar-Gómez F.J., Climent-Barberá J.M., Cholbi-Llobel F. Randomized controlled study of the efficacy of the injection of botulinum toxin type A versus corticosteroids in chronic plantar fasciitis: Results at one and six months. Clin Rehabil 2012, 26:594-606.
5. Ryan M.B., Wong A.D., Gillies J.H., Wong J., Taunton J.E. Sonographically guided intratendinous injections of hyperosmolar dextrose/lidocaine: A pilot study for the treatment of chronic plantar fasciitis. Br J Sports Med 2009, 43:303-306.
6. Scioli M.W. Platelet-rich plasma injection for proximal plantar fasciitis. Tech Foot Ankle 2011, 10:7-10.
7. League A.C. Current concepts reviews: Plantar fasciitis. Foot Ankle Int 2008, 29:358-366.
8. Cole C., Seto C., Gazewood J. Plantar fasciitis: Evidence-based review of diagnosis and therapy. Am Family Phys 2005, 72:2237-2242.
9. Buchbinder R. Clinical practice. Plantar fasciitis. NEngl J Med 2004, 350:2159-2166.
10. Lemont H., Ammirati K.M., Usen N. Plantar fasciitis: A degenerative process (fasciosis) without inflammation. JAm Podiatr Med Assoc 2003, 93:234-237.
11. Rabago D., Best T., Beamsly M., Patterson J. Asystematic review of prolotherapy for chronic musculoskeletal pain. Clin J Sports Med 2005, 15:376-380.
12. Rabago D., Slattengren A., Zgierska A. Prolotherapy in primary care practice. Prim Care 2010, 37:65-80.
13. Rabago D., Best T.M., Zgierska A.E., Zeisig E., Ryan M., Crane D. Asystematic review of four injection therapies for lateral epicondylosis: Prolotherapy, polidocanol, whole blood and platelet-rich plasma. Br J Sports Med 2009, 43:471-481.
14. Scarpone M., Rabago D.P., Zgierska A., Arbogast G., Snell E. The efficacy of prolotherapy for lateral epicondylosis: A pilot study. Clin J Sport Med 2008, 18:248-254.
15. Jensen K.T., Rabago D.P., Best T.M., Patterson J.J., Vanderby R. Response of knee ligaments to prolotherapy in a rat injury model. Am J Sports Med 2008, 36:1347-1357.
16. Jensen K.T., Rabago D.P., Best T.M., Patterson J.J., Vanderby R. Early inflammatory response of knee ligaments to prolotherapy in a rat model. JOrthop Res 2008, 26:816-823.
17. Topol G.A., Reeves K.D., Hassanein K.M. Efficacy of dextrose prolotherapy in elite male kicking-sport athletes with chronic groin pain. Arch Phys Med Rehabil 2005, 86:697-702.
18. Okuda Y., Adrogue H.J., Nakajima T., et al. Increased production of PDGF by angiotensin and high glucose in human vascular endothelium. Life Sci 1996, 59:1455-1461.
19. Oh J.H., Ha H., Yu M.R., Lee H.B. Sequential effects of high glucose on mesangial cell transforming growth factor-beta 1 and fibronectin synthesis. Kidney Int 1998, 54:1872-1878.
20. Di Paolo S., Gesualdo L., Ranieri E., Grandaliano G., Schena F.P. High glucose concentration induces the overexpression of transforming growth factor-beta through the activation of a platelet-derived growth factor loop in human mesangial cells. Am J Pathol 1996, 149:2095-2106.
21. Kampa R.J., Connell D.A. Treatment of tendinopathy: Is there a role for autologous whole blood and platelet rich plasma injection?. Int J Clin Pract 2010, 64:1813-1823.
22. Peerbooms J.C., Sluimer J., Bruijn D.J., Gosens T. Positive effect of an autologous platelet concentrate in lateral epicondylitis in a double-blind randomized controlled trial: Platelet-rich plasma versus corticosteroid injection with a 1-year follow-up. Am J Sports Med 2010, 38:255-262.
23. Gosens T., Peerbooms J.C., van Laar W., denOudsten B.L. Ongoing positive effect of platelet-rich plasma versus corticosteroid injection in lateral epicondylitis: A double-blind randomized controlled trial with 2-year follow-up. Am J Sports Med 2011, 39:1200-1208.
24. Budiman-Mak E., Conrad K.J., Roach K.E. The Foot Function Index: A measure of foot pain and disability. JClin Epidemiol 1991, 44:561-570.
25. Aspenberg P., Virchenko O. Platelet concentrate injection improves Achilles tendon repair in rats. Acta Orthop Scand 2004, 75:93-99.
26. Creaney L., Wallace A., Curtis M., Connell D. Growth factor-based therapies provide additional benefit beyond physical therapy in resistant elbow tendinopathy: A prospective, single-blind, randomised trial of autologous blood injections versus platelet-rich plasma injections. Br J Sports Med 2011, 45:966-971.
27. Thanasas C., Papadimitriou G., Charalambidis C., Paraskevopoulos I., Papanikolaou A. Platelet-rich plasma versus autologous whole blood for the treatment of chronic lateral elbow epicondylitis: A randomized controlled clinical trial. Am J Sports Med 2011, 39:2130-2134.
28. Tatli Y.Z., Kapasi S. The real risks of steroid injection for plantar fasciitis, with a review of conservative therapies. Curr Rev Musculoskelet Med 2009, 2:3-9.
29. Murphy M., Godson C., Cannon S., et al. Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells. JBiol Chem 1999, 274:5830-5834.
30. Fukuda K., Kawata S., Inui Y., et al. High concentration of glucose increases mitogenic responsiveness to heparin-binding epidermal growth factor-like growth factor in rat vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 1997, 17:1962-1968.
31. Kon E., Mandelbaum B., Buda R., et al. Platelet-rich plasma intra-articular injection versus hyaluronic acid viscosupplementation as treatments for cartilage pathology: From early degeneration to osteoarthritis. Arthroscopy 2011, 27:1490-1501.
32. Alsousou J., Thompson M., Hulley P., Noble A., Willett K. The biology of platelet-rich plasma and its application in trauma and orthopaedic surgery: A review of the literature. JBone Joint Surg Br 2009, 91:987-996.
33. Davidson J., Jayaraman S. Guided interventions in musculoskeletal ultrasound: What's the evidence?. Clin Radiol 2011, 66:140-152.
34. Kon E., Filardo G., Delcogliano M., et al. Platelet-rich plasma: New clinical application: A pilot study for treatment of jumper's knee. Injury 2009, 40:598-603.
35. Hammond J.W., Hinton R.Y., Curl L.A., Muriel J.M., Lovering R.M. Use of autologous platelet-rich plasma to treat muscle strain injuries. Am J Sports Med 2009, 37:1135-1142.
36. Marx R.E. Platelet-rich plasma: Evidence to support its use. JOral Maxillofac Surg 2004, 62:489-496.
37. Weibrich G., Hansen T., Kleis W., Buch R., Hitzler W.E. Effect of platelet concentration in platelet-rich plasma on peri-implant bone regeneration. Bone 2004, 34:665-671.
38. Everts P.A., Knape J.T., Weibrich G., et al. Platelet-rich plasma and platelet gel: A review. JExtra Corpor Technol 2006, 38:174-187.
39. Anitua E., Andia I., Ardanza B., Nurden P., Nurden A.T. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost 2004, 91:4-15.